Objective: Standardized case definitions have recently been proposed by the International Network for the Study of HIV-associated immune reconstitution inflammatory syndrome (INSHI; [IRIS]) for use in resource-limited settings. We evaluated paradoxical tuberculosis (TB)-associated IRIS in a large cohort from a TB endemic setting with the use of these case definitions.
Introduction
Tuberculosis (TB) is one of the most common opportunistic infections seen in patients commencing combined antiretroviral therapy (ART) in sub-Saharan Africa, with up to 67% of patients reported to have either previous or current TB on entry into ART programs. 1 One of the most frequent complications associated with the initiation of ART in patients with concomitant TB is immune reconstitution inflammatory syndrome (IRIS). Tuberculosis-associated IRIS in coinfected patients is most often self-limiting but may significantly complicate the management of both conditions and the assessment of clinical deterioration. 2, 3 In these patients, TB-associated IRIS may manifest as clinical deterioration in a patient already stabilized on antituberculous therapy (ATT), this is known as paradoxical TB-associated IRIS. Alternatively TB-associated IRIS may occur as a new presentation of TB coupled with marked inflammatory manifestations (unmasking TB-associated IRIS).
Previous studies from low-/middle-and high-income countries report 8% to 13% and 17% to 43% of patients developing paradoxical TB-associated IRIS, respectively. [3] [4] [5] [6] [7] [8] [9] [10] [11] This reflects the significant differences in the study populations, case definitions, and timing of ART initiation in these cohorts.
Standardized case definitions for TB-associated IRIS have been proposed by the International Network for the Study of HIV-associated IRIS (INSHI), for use in resource-limited settings. 12, 13 Such case definitions will assist in decreasing the reliance on laboratory tests and standardize reporting of TB-associated IRIS in these areas.
We undertook a descriptive study of TB-associated IRIS in a TB endemic setting with the use of the INSHI case definitions.
Methods
Records were reviewed from 1250 HIV-infected patients commencing ART at an antiretroviral clinic in Cape Town, South Africa, between January 1, 2003, and May 15, 2008. We aimed to describe the characteristics and determine the proportion of patients with prevalent TB who develop paradoxical TBassociated IRIS, with the aid of the new published case definitions. 13 The Health Research Ethics Review Committee of the University of Stellenbosch approved the protocol.
A total of 1250 (77%) patient records were reviewed from the total number (1621) of available adult patients commencing ART at the facility during the study period. The cases not reviewed in this study represent missing clinical records at the time of data collection. Although clinical records were not available for these missing cases, their baseline laboratory results and demographic data were accessible via the hospital database. The study sample did not statistically differ from the remaining clinic population with regard to median pre-ART CD4 count (120 cell/mm 3 and 115 cells/mm 3 , respectively), gender (female gender: 61% and 67%, respectively), mean age (37 years and 38 years, respectively), proportion of deceased (7% and 6%, respectively), and the proportion of patients lost to follow-up prior to completing 3 months of ART (1% and 2%, respectively). Antiretroviral therapy was administered at an outpatient facility within an academic hospital. All patients were ARTnaive and were commenced on an ART regimen including stavudine ([d4T]; or zidovudine [ZDV]), lamivudine (3TC), and efavirenz ([EFV]; or nevirapine [NVP]). Antituberculous therapy was administered at various separate communitybased TB clinics. World Health Organization (WHO) TB case definitions were used to identify TB cases at the TB clinics and at the ART site. 14 Records from the outpatient ART clinic were evaluated for TB history and evidence of paradoxical TB-associated IRIS (TB IRIS) during the first 3 months of ART. A case was defined as having at least 1 major criterion or 2 minor criteria for TB IRIS as well as fulfilling antecedent requirements and having no alternative explanations for clinical deterioration (Table 1) . Patients who did not return for follow-up or were transferred to other facilities prior to completing 3 months of ART were excluded from the IRIS analysis.
Statistica Version 8 was used to analyze descriptive statistics and to evaluate significance. For the bivariate analyses, the chi-square test was used to analyze categorical variables and the Mann-Whitney U test was used to analyze continuous variables. All statistical tests were performed at the 5% alpha significance level, and were 2-tailed.
Results
There were 333 patients (27%) with prevalent TB at baseline. Among these patients, a median of 99 days (interquartile range [IQR]: 62-155 days) of ATT had been completed prior to the initiation of ART. There were 9 cases of multidrug resistant (MDR) TB among the prevalent TB cases (3%). In all, 10 patients on ATT were transferred to other facilities and another 10 patients became lost to follow-up prior to completing 3 months of ART. These 20 patients were excluded from further analysis. Of the 313 prevalent TB cases included, 6 were found to be responding poorly to ATT prior to ART initiation. Of the remaining 307 patients, 54 had a clinical deterioration during the first 3 months of ART initiation and were suspected by clinicians to have TB IRIS. Among these, 12 had other medical issues as a cause for their clinical deterioration. Of the remaining 42 possible TB IRIS cases, 7 presented with only 1 minor criterion, thereby not fulfilling the INSHI case definition ( Table 1 ). These cases consisted of 4 patients with isolated constitutional symptoms, 2 with worsening cough, and 1 with worsening hepatomegaly.
According to the INSHI case definition, the proportion of patients with TB IRIS was 11% (35 out of 313 patients). These patients presented with symptoms at a median of 18 days (IQR 14-28 days) after ART initiation. The majority had at least 1 major criterion (n ¼ 24, 68%) and a smaller proportion (n ¼ 11, 32%) were diagnosed by fulfilling at least 2 minor criteria.
In the bivariate analysis, the only variable found to be significantly associated with the development of TB IRIS in this cohort was a low pre-ART CD4 count ( Table 2 ). Tuberculosis occurred in 19% of patients with a CD4 count of less than 50 cells/mm 3 , in 10% of those with a CD4 count between 50 and 100 cells/mm 3 , and in 5.4% of patients with CD4 counts greater than 100 cells/mm 3 . Extrapulmonary TB (EPTB) was not found to be significantly associated with TB IRIS in this cohort.
Mortality among TB IRIS cases was low, with one possible associated death (2%). This occurred in a patient diagnosed with smear-positive pulmonary TB who commenced ART 7 days after the initiation of ATT. She presented 13 days after ART initiation with marked respiratory symptoms and worsening pulmonary infiltrates and died in hospital 27 days later. Antituberculous therapy drug resistance results were not available and oral corticosteroids were administered in this case. No autopsy was performed.
In all, 19 patients (54%) with TB IRIS required either hospitalization and/or the administration of oral corticosteroids during the episode; 8 (23%) patients were hospitalized and 13 (37%) received oral corticosteroid therapy. Symptoms among the 7 patients who were not included in the IRIS case definition due to insufficient criteria resolved spontaneously.
Discussion
The proportion of patients who developed TB IRIS was 11% in our cohort when the INSHI case definition was applied; this is in keeping with the 8% to 13% figures reported from previous studies in resource-limited settings. [3] [4] [5] The use of the proposed case definitions worked well for identifying cases with significant manifestations, although it is possible that some of the patients whose symptoms failed to meet the case definitions represented milder cases of TB IRIS and were excluded.
The incidence of TB IRIS among the 10 TB-coinfected patients, who were lost to follow-up prior to completing 3 months of ART, is unknown. It is possible that some missed cases of TB IRIS may have occurred in this group and lead to a lower reported proportion of TB IRIS cases and related mortalities.
Reports from previous cohort studies on the risk factors for the development of TB IRIS have been variable and somewhat inconsistent. The presence of a low baseline CD4 count, 3,7 EPTB, 5-8 and a shorter interval time on ATT prior to ART 3,8-10 have been identified as potential predictors. In our cohort a low baseline CD4 count was strongly associated with the development of TB IRIS ( Table 2) .
The lack of association with EPTB was found when the effect was evaluated using WHO case definitions and when the analysis was repeated among patients with any EPTB manifestations ( Table 2 ). This finding may have been influenced by the potential underdiagnosis of EPTB in resource-limited settings. 3 The duration of time spent on ATT prior to ART initiation was found to have no significant effect on the development of IRIS in this cohort. These results may have been affected by inaccuracies in data on the timing of initiation of TB treatment from peripheral TB clinics.
Among possible IRIS cases in this cohort, only 1 patient was identified as having MDR TB. This is in contrast with recent data which show that up to 10% of patients who are assessed as having paradoxical TB IRIS may have rifampicin resistance. 15 Rapid testing for rifampicin resistance was not available at the facility during the study period, which may have lead to an underdiagnosis of the number of MDR TB cases.
Morbidity associated with TB IRIS was high, 19 (54%) of patients required intervention, either hospitalization or corticosteroid usage. Rifampicin resistance should ideally be excluded prior to initiating corticosteriods in patients with suspected TB IRIS. 15, 16 To our knowledge, this is the largest cohort studied to date assessing risk factors and outcomes of paradoxical TB-associated IRIS according to the standardized case definitions proposed by INSHI for use in resource-limited settings. 13 This study was, however, markedly limited by the use of retrospective data.
The INSHI standardized case definitions were used successfully in identifying paradoxical TB-associated IRIS in this cohort. Their validation with other previously reported case definitions should be conducted prospectively.
